BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6088215)

  • 21. The relationship between epilepsy and schizophrenia: a biochemical hypothesis.
    Trimble M
    Biol Psychiatry; 1977 Apr; 12(2):299-304. PubMed ID: 15665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 23. Does the dopamine hypothesis explain schizophrenia?
    Lau CI; Wang HC; Hsu JL; Liu ME
    Rev Neurosci; 2013; 24(4):389-400. PubMed ID: 23843581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor.
    Snyder SH
    Am J Psychiatry; 1976 Feb; 133(2):197-202. PubMed ID: 1251927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of beta-endorphin on catecholamine levels in the rat hypothalamus and cerebral cortex].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV
    Biull Eksp Biol Med; 1986 May; 101(5):562-4. PubMed ID: 2939890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low frontal glucose utilization in chronic schizophrenia: a replication study.
    Wolkin A; Angrist B; Wolf A; Brodie JD; Wolkin B; Jaeger J; Cancro R; Rotrosen J
    Am J Psychiatry; 1988 Feb; 145(2):251-3. PubMed ID: 3257653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endorphins and endogenous psychoses].
    Naber D; Pickar D
    Nervenarzt; 1984 Jul; 55(7):378-81. PubMed ID: 6089011
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain amines and peptides--their relevance to psychiatry.
    Smith GC; Copolov D
    Aust N Z J Psychiatry; 1979 Dec; 13(4):283-91. PubMed ID: 44187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypothetical concept: the physiopathological entity of monoaminergic psychoses].
    Tissot R
    Encephale; 1975; 1(4):289-339. PubMed ID: 1082812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Brain imaging in schizophrenia -- especially by Computed Tomography].
    Szulc A
    Psychiatr Pol; 1994; 28(2):145-56. PubMed ID: 8208861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Various biochemical aspects of the concept of inhibition in psychiatry].
    Tissot R
    Encephale; 1978; 4(5 Suppl):513-20. PubMed ID: 753613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [X-ray computed tomography (CT scanner) in schizophrenia. Comparison of its results with other studies].
    Messimy R; Lopez-Ibor JJ; Lopez-Ibor L; Loo H; Metzger J; Deniker P
    Encephale; 1984; 10(2):69-77. PubMed ID: 6468336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine in schizophrenia: a review and reconceptualization.
    Davis KL; Kahn RS; Ko G; Davidson M
    Am J Psychiatry; 1991 Nov; 148(11):1474-86. PubMed ID: 1681750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The biology of schizophrenia: current status and perspectives of its knowledge].
    Díaz JL
    Rev Invest Clin; 1986; 38(1):89-110. PubMed ID: 2874601
    [No Abstract]   [Full Text] [Related]  

  • 37. Binding sites for non-opioid gamma-type endorphins in brain structures of the mesocorticolimbic feedback circuit.
    Wiegant VM; Ronken E; de Boer T; Tonnaer JA
    Prog Clin Biol Res; 1990; 328():29-32. PubMed ID: 1689494
    [No Abstract]   [Full Text] [Related]  

  • 38. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuropeptides, dopamine, and schizophrenia.
    Nemeroff CB; Bissette G
    Ann N Y Acad Sci; 1988; 537():273-91. PubMed ID: 3059929
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neurobiological determinants of schizophrenic diseases. Concept, strategy and methods of a research program].
    Gaebel W; Maier W
    Nervenarzt; 1993 Jul; 64(7):415-26. PubMed ID: 8396208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.